| Financial Year |
March 31 2023 |
| Monetary Funds |
378,486,889.85 |
| Held-for-trading Financial Assets |
120,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
237,512,539.46 |
| Advances to Suppliers |
58,935,494.49 |
| Other Receivables |
55,189,474.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
487,372,098.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,417,295.28 |
| Total Current Assets |
1,358,913,791.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,781.70 |
| Fixed Assetes |
1,856,499,353.83 |
| Under-construction Projects |
89,638,310.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
105,654,941.13 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
128,006,834.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,549,635.40 |
| Deferred Income Tax Assets |
319,093.69 |
| Other Non-Current Assets |
20,984,873.58 |
| Sub-Total of Non-Current Assets |
2,296,163,648.85 |
| Total Assets |
3,655,077,440.83 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
185,683,561.73 |
| Accounts Received In Advance |
1,559,460.96 |
| Employee Compensation Payable |
36,753,678.13 |
| Taxes Payable |
2,348,366.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
234,672,108.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
67,403,772.44 |
| Other Current Liabilities |
8,163,787.92 |
| Sub-Total of Current Liabilities |
603,624,809.11 |
| Long-term Loans |
482,090,000.00 |
| Bonds Payable |
534,415,105.12 |
| Long-Term Accounts Payable |
14,054,552.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,166,443,830.29 |
| Total Liabilities |
1,770,068,639.40 |
| Paid-In Capital(Or Share Stock) |
101,881,104.00 |
| Capital Surplus |
726,243,552.68 |
| Surplus Reserve |
50,940,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
807,079,587.00 |
| Minority Stockholder's Interest |
80,244,183.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,804,764,617.75 |
| Owner's Equity（Stockholder's Equity） |
1,885,008,801.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,655,077,440.83 |
